On 2^nd Sept. 2016, Medical Economics, the authoritative media in China pharmaceutical industry, published bylined articles “Speeding up hydroxyethyl starch substitution from importing to domestic manufacturing”, reported our leading product of hydroxyethyl starch 130/20.4 had obtained CEP certificates. It pointed out that EDQM only issued 3 CEP certificates of HES130/20.4 globally, and this is the first one awarded to Chinese manufacturer.

Link: http://www.yyjjb.com/html/2016-09/202/node_4182.htm